Duarte, CALIFORNIA4 Active Studies

Myelofibrosis Clinical Trials in Duarte, CALIFORNIA

Find 4 actively recruiting myelofibrosis clinical trials in Duarte, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,107
Enrolling

Recruiting Myelofibrosis Studies in Duarte

RecruitingDuarte, CALIFORNIANCT03165734

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia ...

399 participants
Swedish Orphan Biovitrum
View Study Details
RecruitingDuarte, CALIFORNIANCT04562389

Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis

This is a global, multicenter, 2-part study to evaluate the efficacy and safety of selinexor plus ruxolitinib in JAK inhibitor (JAKi) treatment-naïve myelofibrosis (MF) participants. The study will be...

350 participants
Karyopharm Therapeutics Inc
View Study Details
RecruitingDuarte, CALIFORNIANCT04176198

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

240 participants
Sumitomo Pharma America, Inc.
View Study Details
RecruitingDuarte, CALIFORNIANCT05980806

A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

The main purpose of this study with corresponding optional expansion is to evaluate the efficacy of selinexor in JAKi-naïve participants with myelofibrosis (MF) and moderate thrombocytopenia based on ...

118 participants
Karyopharm Therapeutics Inc
View Study Details

About Myelofibrosis Clinical Trials in Duarte

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 4 myelofibrosis clinical trials recruiting participants in Duarte, CALIFORNIA. These studies are seeking a combined 1,107 participants. Research is being sponsored by Swedish Orphan Biovitrum, Karyopharm Therapeutics Inc, Sumitomo Pharma America, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Duarte — FAQ

Are there myelofibrosis clinical trials in Duarte?

Yes, there are 4 myelofibrosis clinical trials currently recruiting in Duarte, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 4 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated March 2, 2026 from ClinicalTrials.gov